Clinical Trials Browser

Phase 2 × olaratumab × Thoracic × Clear all

NCT00918203 2019-01-10

A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

137 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms